Muscle Strain
Of the 5 unique stories with a clear outcome, 5 reported it helped (100%).
These are public YouTube testimonials, not clinical evidence. People who tried BPC-157 and got no result rarely post videos — read this as a sample of the positive end of the distribution.
“I saw a significant decrease in inflammation and pain within the first 10 to 15 days”
“I did experience less post-workout soreness”
“it is helping, it is helping tremendously”
“the injury healed up”
“better the next day”
Related research
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review.
This review concludes that BPC 157, a stable gastric pentadecapeptide, shows promise in treating complex musculoskeletal and junctional injuries, with efficacy in tendon, ligament, and muscle healing. BPC 157 appears to have a full cytoprotection range and can be administered systemically or locally without a carrier.
Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in Rats.
This study found that BPC-157 therapy promoted muscle-to-bone reattachment and restored muscle function in rats with detached quadriceps muscles. The therapy showed consistent healing effects at various time points, leading to well-organized bone formation and mature muscle fibers.
Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats.
This study found that BPC-157 therapy promotes healing and functional recovery of disabled myotendinous junctions in rats, counteracting muscle atrophy and oxidative stress. The treatment led to complete disappearance of defects and restoration of normal muscle presentation in treated rats.
BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmias.
BPC 157 was shown to counteract the effects of succinylcholine, including hyperkalemia, arrhythmias, and muscle damage, in rats. The peptide mitigated local and systemic disturbances and eliminated hyperkalemia, arrhythmias, and post-succinylcholine hyperalgesia.